Literature DB >> 26299228

Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.

Vicente F Corrales-Medina1, Monica Taljaard2, Sachin Yende3, Richard Kronmal4, Girish Dwivedi5, Anne B Newman6, Mitchell S V Elkind7, Mary F Lyles8, Julio A Chirinos9.   

Abstract

BACKGROUND: Pneumonia is associated with high risk of heart failure (HF) in the short term (30 days) postinfection. Whether this association persists beyond this period is unknown.
METHODS: We studied 5,613 elderly (≥65 years) adults enrolled in the Cardiovascular Health Study between 1989 and 1994 at 4 US communities. Participants had no clinical diagnosis of HF at enrollment, and they were followed up through December 2010. Hospitalizations for pneumonia were identified using validated International Classification of Disease Ninth Revision codes. A centralized committee adjudicated new-onset HF events. Using Cox regression, we estimated adjusted hazard ratios (HRs) of new-onset HF at different time intervals after hospitalization for pneumonia.
RESULTS: A total of 652 participants hospitalized for pneumonia during follow-up were still alive and free of clinical diagnosis of HF by day 30 posthospitalization. Relative to the time of their hospitalization, new-onset HF occurred in 22 cases between 31 and 90 days (HR 6.9, 95% CI 4.46-10.63, P < .001), 14 cases between 91 days and 6 months (HR 3.2, 95% CI 1.88-5.50, P < .001), 20 cases between 6 months and 1 year (HR 2.6, 95% CI 1.64-4.04, P < .001), 76 cases between 1 and 5 years (HR 1.7, 95% CI 1.30-2.12, P < .001), and 71 cases after 5 years (HR 2.0, 95% CI 1.56-2.58, P < .001). Results were robust to sensitivity analyses using stringent definitions of pneumonia and extreme assumptions for potential informative censoring.
CONCLUSION: Hospitalization for pneumonia is associated with increased risk of new-onset HF in the intermediate and long term. Studies should characterize the mechanisms of this association in order to prevent HF in elderly pneumonia survivors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26299228      PMCID: PMC4548825          DOI: 10.1016/j.ahj.2015.04.028

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  36 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  National Hospital Discharge Survey: 2007 summary.

Authors:  Margaret Jean Hall; Carol J DeFrances; Sonja N Williams; Aleksandr Golosinskiy; Alexander Schwartzman
Journal:  Natl Health Stat Report       Date:  2010-10-26

3.  Population burden of long-term survivorship after severe sepsis in older Americans.

Authors:  Theodore J Iwashyna; Colin R Cooke; Hannah Wunsch; Jeremy M Kahn
Journal:  J Am Geriatr Soc       Date:  2012-05-29       Impact factor: 5.562

4.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

5.  Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts.

Authors:  Sachin Yende; Karina Alvarez; Laura Loehr; Aaron R Folsom; Anne B Newman; Lisa A Weissfeld; Richard G Wunderink; Stephen B Kritchevsky; Kenneth J Mukamal; Stephanie J London; Tamara B Harris; Doug C Bauer; Derek C Angus
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

6.  Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

Authors:  Vicente F Corrales-Medina; Daniel M Musher; George A Wells; Julio A Chirinos; Li Chen; Michael J Fine
Journal:  Circulation       Date:  2012-01-04       Impact factor: 29.690

Review 7.  Epidemiology of fracture risk with advancing age.

Authors:  Kristine E Ensrud
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-05       Impact factor: 6.053

Review 8.  Community-acquired pneumonia.

Authors:  Mark Loeb
Journal:  BMJ Clin Evid       Date:  2010-08-18

9.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

10.  Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults.

Authors:  Catherina L Chang; Graham D Mills; Noel C Karalus; Lance C Jennings; Richard Laing; David R Murdoch; Stephen T Chambers; Dominic Vettise; Christine M Tuffery; Robert J Hancox
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more
  19 in total

1.  Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Authors:  Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

Review 2.  Stroke Risk Factors, Genetics, and Prevention.

Authors:  Amelia K Boehme; Charles Esenwa; Mitchell S V Elkind
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis.

Authors:  Leah B Kosyakovsky; Federico Angriman; Emma Katz; Neill K Adhikari; Lucas C Godoy; John C Marshall; Bruno L Ferreyro; Douglas S Lee; Robert S Rosenson; Naveed Sattar; Subodh Verma; Augustin Toma; Marina Englesakis; Barry Burstein; Michael E Farkouh; Margaret Herridge; Dennis T Ko; Damon C Scales; Michael E Detsky; Lior Bibas; Patrick R Lawler
Journal:  Intensive Care Med       Date:  2021-08-09       Impact factor: 17.440

4.  Infiltrated Macrophages Die of Pneumolysin-Mediated Necroptosis following Pneumococcal Myocardial Invasion.

Authors:  Ryan P Gilley; Norberto González-Juarbe; Anukul T Shenoy; Luis F Reyes; Peter H Dube; Marcos I Restrepo; Carlos J Orihuela
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

5.  Long-term impact of sepsis on cardiovascular health.

Authors:  R T Mankowski; S Yende; D C Angus
Journal:  Intensive Care Med       Date:  2018-05-08       Impact factor: 17.440

6.  Persistent Lung Inflammation After Clinical Resolution of Community-Acquired Pneumonia as Measured by 18FDG-PET/CT Imaging.

Authors:  Vicente F Corrales-Medina; Robert A deKemp; Julio A Chirinos; Wanzhen Zeng; Jerry Wang; Grant Waterer; Rob S B Beanlands; Girish Dwivedi
Journal:  Chest       Date:  2021-03-03       Impact factor: 10.262

7.  The best of respiratory infections from the 2015 European Respiratory Society International Congress.

Authors:  Eva Polverino; Graham H Bothamley; Delia Goletti; Jan Heyckendorf; Giovanni Sotgiu; Stefano Aliberti
Journal:  ERJ Open Res       Date:  2016-07-11

8.  Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up.

Authors:  Dean T Eurich; Thomas J Marrie; Jasjeet K Minhas-Sandhu; Sumit R Majumdar
Journal:  BMJ       Date:  2017-02-13

Review 9.  Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Pneumonia (Nathan)       Date:  2016-07-21

10.  Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease.

Authors:  Rebecca Bornheimer; Kimberly M Shea; Reiko Sato; Derek Weycker; Stephen I Pelton
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.